← Back to Search

Ischemic & Hemorrhagic stroke patients for Hemorrhagic Stroke (VERIFY Trial)

N/A
Recruiting
Led By Achala Vagal, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-stroke
Awards & highlights

Summary

VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.

Eligible Conditions
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-stroke
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post-stroke for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Action Research Arm Test (ARAT) for AIM 2
Upper Extremity-Fugl Meyer (UE-FM) for AIM 1
Other outcome measures
Motor Activity Log (MAL)
modified Rankin Score (mRS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ischemic & Hemorrhagic stroke patientsExperimental Treatment1 Intervention
557 ischemic stroke patients and 100 hemorrhagic stroke patients
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation (TMS)
2018
Completed Phase 4
~550

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
433 Previous Clinical Trials
635,746 Total Patients Enrolled
4 Trials studying Hemorrhagic Stroke
3,660 Patients Enrolled for Hemorrhagic Stroke
University of California, Los AngelesOTHER
1,554 Previous Clinical Trials
10,263,457 Total Patients Enrolled
1 Trials studying Hemorrhagic Stroke
900 Patients Enrolled for Hemorrhagic Stroke
University of Auckland, New ZealandOTHER
74 Previous Clinical Trials
116,716 Total Patients Enrolled
~328 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top